Neuropsychological outcome following unilateral pallidotomy

Brain

Volumn 122, Issue 12, 1999, Pages 2209-2220

  York, Michele K ^a   Levin, Harvey S ^a   Grossman, Robert G ^a   Hamilton, Winifred J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cognition; Neuropsychology; Outcome; Pallidotomy; Parkinson's disease

Indexed keywords

COGNITION; HUMAN; NEUROPSYCHOLOGY; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AFFECT; FORECASTING; GLOBUS PALLIDUS; HUMANS; MENTAL PROCESSES; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PATIENT SELECTION; STEREOTAXIC TECHNIQUES; THALAMIC NUCLEI; TREATMENT OUTCOME;

EID: 0032754719     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.12.2209     Document Type: Review

References (87)

1. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [see comments]. Arch Neurol 1996; 40: 355-66. Comment in: Arch Neurol 1996; 40: 341-3, Comment in: Arch Neurol 1997; 41: 834-6, Comment in: Arch Neurol 1996; 42: 129-30.
2. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [see comments]. Arch Neurol 1996; 40: 355-66. Comment in: Arch Neurol 1996; 40: 341-3, Comment in: Arch Neurol 1997; 41: 834-6, Comment in: Arch Neurol 1996; 42: 129-30.
3. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [see comments]. Arch Neurol 1996; 40: 355-66. Comment in: Arch Neurol 1996; 40: 341-3, Comment in: Arch Neurol 1997; 41: 834-6, Comment in: Arch Neurol 1996; 42: 129-30.
4. Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [see comments]. Arch Neurol 1996; 40: 355-66. Comment in: Arch Neurol 1996; 40: 341-3, Comment in: Arch Neurol 1997; 41: 834-6, Comment in: Arch Neurol 1996; 42: 129-30.
5. Bowen FP, Kamienny RS, Burns MM, Yahr M. Parkinsonism: effects of levodopa treatment on concept formation. Neurology 1975; 25: 701-4.
6. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet 1984; 2: 1262-5.
7. Bryk AS, Raudenbush SW. Hierarchical linear models: applications and data analysis methods. Newbury Park (CA): Sage Publications; 1992.
8. Cahn DA, Sullivan EV, Shear PK, Heit G, Lim KO, Marsh L, et al. Neuropsychological and motor functioning after unilateral anatomically guided posterior ventral pallidotomy. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11: 136-45.
9. Collins LM, Horn JL. Best methods for the analysis of change: recent advances, unanswered questions, future directions. Washington (DC): American Psychological Association; 1991.
10. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095-122.
11. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A followup study of untreated patients. Brain 1992; 115: 1701-25.
12. Crosson B. Subcortical functions in language: a working model. [Review]. Brain Lang 1985; 25: 257-92.
13. Cummings JL. The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. [Review]. Eur Neurol 1988; 28 Suppl 1: 15-23.
14. Damasio AR. Language and the basal ganglia. Trends Neurosci 1983; 6: 442-4.
15. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997; 48: 1277-81.
16. de Smet Y, Ruberg M, Serdaru M, Dubois B, Lhermitte F, Agid Y. Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry 1982; 45: 1161-4.
17. Desaloms JM, Krauss JK, Lai EC, Jankovic J, Grossman RG. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome. J Neurosurg 1998; 89: 194-9.
18. Dodrill CB, Troupin AS. Effects of repeated administrations of a comprehensive neuropsychological battery among chronic epileptics. J Nerv Ment Dis 1975; 161: 185-90.
19. Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995; 45: 753-61.
20. Dubois B, Danze F, Pillon B, Cuismano G, Lhermitte F, Agid Y. Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol 1987; 22: 26-30.
21. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997; 48: 1273-7.
22. Glatt SL, Hubble JP, Lyons K, Paolo A, Troster AI, Hassanein RE, et al. Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology 1996; 15: 20-5.
23. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988; 111: 299-321.
24. Green J, Barnhart H. The impact of lesion laterality on neuropsychological change following posterior pallidotomy: a review of current findings. Brain Cogn. In press 1999.
25. Growden JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group. Neurology 1998; 50: 1327-31.
26. Hannay HJ, Levin HS. Selective reminding test: an examination of the equivalence of four forms. J Clin Exp Neuropsychol 1985; 7: 251-63.
27. Hariz MI. Controversies in pallidal surgery. [Review]. Acta Neurochir (Wien) 1999; Suppl 68: 1-10.
28. Hersen M, Barlow DH. Single case experimental designs. Elmsford (NY): Pergamon Press; 1976.
29. Huber SJ, Shulman JG, Paulson GW, Shuttleworth EC. Dose-dependent memory impairment in Parkinson's disease. Neurology 1989; 39: 438-40.
30. Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeaux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995; 45: 1691-6.
31. Jacques D, Eagle KS, Kopyov OV. Use of posteroventral pallidotomy for treatment of Parkinson's disease: is pallidotomy still an experimental procedure? A review and commentary. (Review). Stereotact Funct Neurosurg 1998; 70: 19-31.
32. Jankovic J, Ben-Arie L, Schwartz K, Chen K, Khan M, Lai EC, et al. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord 1999; 14: 57-62.
33. Katzen HL, Levin BE, Llabre ML. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc 1998; 4: 285-90.
34. Kishore A, Turnbull IM, Snow BJ, de la Fuente-Fernandez R, Schulzer M, Mak E, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 1997; 120: 729-37.
35. Kondziolka D, Bonaroti E, Baser S, Brandt F, Kim YS, Lunsford LD. Outcomes after stereotactically guided pallidotomy for advanced Parkinson's disease. J Neurosurg 1999; 90: 197-202.
36. Kopyov O, Jacques D, Duma C, Buckwalter G, Kopyov A, Lieberman A, et al. Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease. J Neurosurg 1997; 87: 52-9.
37. Kraemer HC, Thiemann S. How many subjects? London: Sage Publications; 1987.
38. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease [see comments]. J Neurosurg 1992; 76: 53-61. Comment in: J Neurosurg 1992; 77: 487-8.
39. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease [see comments]. J Neurosurg 1992; 76: 53-61. Comment in: J Neurosurg 1992; 77: 487-8.
40. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease [see comments]. N Engl J Med 1997; 337: 1036-42. Comment in: N Engl J Med 1997; 338: 262-3.
41. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease [see comments]. N Engl J Med 1997; 337: 1036-42. Comment in: N Engl J Med 1997; 338: 262-3.
42. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257-70.
43. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
44. Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, et al. Dementia in Parkinson disease. Ann Neurol 1979; 6: 355-9.
45. Lieberman RR, Ellenberg M, Restum WH. Aphasia associated with verified subcortical lesions: three case reports. Arch Phys Med Rehabil 1986; 67: 410-4.
46. Lipsey MW. Design sensitivity: statistical power for experimental research. Newbury Park (CA): Sage Publications; 1990.
47. Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, et al. Effects of GPi pallidotomy on motor function in Parkinson's disease [see comments] [published erratum appears in Lancet 1996; 348: 1108]. Lancet 1995; 346: 1383-7. Comment in: Lancet 1996; 347: 1490.
48. Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, et al. Effects of GPi pallidotomy on motor function in Parkinson's disease [see comments] [published erratum appears in Lancet 1996; 348: 1108]. Lancet 1995; 346: 1383-7. Comment in: Lancet 1996; 347: 1490.
49. Lozano AM, Lang AE, Hurchison WD. Pallidotomy for tremor. [Review]. Mov Disord 1998; 13 Suppl 3: 107-10.
50. Mahieux F, Fenelon G, Flahault A, Manifacier ML, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease [see comments]. J Neurol Neurosurg Psychiatry 1998; 64: 178-83. Comment in: J Neurol Neurosurg Psychiatry 1998; 65: 804-5.
51. Mahieux F, Fenelon G, Flahault A, Manifacier ML, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease [see comments]. J Neurol Neurosurg Psychiatry 1998; 64: 178-83. Comment in: J Neurol Neurosurg Psychiatry 1998; 65: 804-5.
52. Mahurin RW, Feher EP, Nance ML, Levy JK, Pirozzolo FJ. Cognition in Parkinson's disease and related disorders. In: Parkes RW, Zec RF, Wilson RS, editors. Neuropsychology of Alzheimer's disease and related disorders. New York: Oxford University Press; 1993. p. 308-49.
53. Masterman D, DeSalles A, Baloh RW, Frysinger R, Foti D, Behnke E, et al. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease. Arch Neurol 1998; 55: 1201-8.
54. Matarazzo JD, Carmody TP, Jacobs LD. Test-retest reliability and stability of the WAIS: a literature review with implications for clinical practice. J Clin Neuropsychol 1980; 2: 89-105.
55. Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 1988; 45: 260-2.
56. McFadden L, Mohr E, Sampson M, Mendis T, Grimes JD. A profile analysis of demented and nondemented Parkinson's disease patients. Adv Neurol 1996; 69: 339-41.
57. Menza MA, Mark MH. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 1994; 6: 165-9.
58. Mortimer JA, Pirozzolo FJ, Hansch EC, Webster DD. Relationship of motor symptoms to intellectual deficits in Parkinson disease. Neurology 1982; 32: 133-7.
59. Nadeau SE, Crosson B. Subcortical aphasia [see comments]. [Review]. Brain Lang 1997; 58: 355-402. Comment in: Brain Lang 1997; 58: 403-9; discussion 436-58.
60. Nadeau SE, Crosson B. Subcortical aphasia [see comments]. [Review]. Brain Lang 1997; 58: 355-402. Comment in: Brain Lang 1997; 58: 403-9; discussion 436-58.
61. Narabayashi H. Pallidotomy revisited. Analysis of posteroventral pallidotomy. Stereotact Funct Neurosurg 1997; 69: 54-61.
62. Newman RP, Weingartner H, Smallberg SA, Calne DB. Effortful and automatic memory: effects of dopamine. Neurology 1984; 34: 805-7.
63. Perrine K, Dogali M, Fazzini E, Sterio D, Kolodny E, Eidelberg D, et al. Cognitive functioning after pallidotomy for refractory Parkinson's disease [see comments]. J Neurol Neurosurg Psychiatry 1998; 65: 150-4. Comment in: J Neurol Neurosurg Psychiatry 1998; 65: 148.
64. Perrine K, Dogali M, Fazzini E, Sterio D, Kolodny E, Eidelberg D, et al. Cognitive functioning after pallidotomy for refractory Parkinson's disease [see comments]. J Neurol Neurosurg Psychiatry 1998; 65: 150-4. Comment in: J Neurol Neurosurg Psychiatry 1998; 65: 148.
65. Pillon B, Dubois B, Bonnet AM, Esteguy M, Guimaraes J, Vigouret JM, et al. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989a; 39: 762-8.
66. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 1989b; 52: 201-6.
67. Portin R, Rinne UK. Neuropsychological responses of parkinsonian patients to long-term levodopa treatment. In: Rinne UK, Klinger M, Stamm G, editors. Parkinson's disease: current progress, problems and management. Amsterdam: Elsevier; 1980. p. 271-304.
68. Portin R, Rinne UK. Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Adv Neurol 1987; 45: 413-6.
69. Prasher D, Findley L. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. J Neurol Neurosurg Psychiatry 1991; 54: 603-9.
70. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 1988; 38: 249-54.
71. Quereshi MY. The comparability of WAIS and WISC subtest scores and IQ estimates. J Psychol 1968; 68: 73-82.
72. Rapport LJ, Axelrod B, Theisen ME, Brines DB, Kalechstein AD, Ricker JH. Relationship of IQ to verbal learning and memory: test and retest. J Clin Exp Neuropsychol 1997; 19: 655-66.
73. Riklan M, Whelihan W, Cullinan T. Levodopa and psychometric test performance in parkinsonism - 5 years later. Neurology 1976; 26: 173-9.
74. Riordan HJ, Flashman LA, Roberts DW. Neurocognitive and psychosocial correlates of ventroposterolateral pallidotomy surgery in Parkinson's disease. Neurosurg Focus 1997; March 97: http:// server400.aans.org/journals/online_j/mar97/2-3-7.html.
75. Robin DA, Schienberg S. Subcortical lesions and aphasia [see comments]. [Review]. J Speech Hear Disord 1990; 55: 90-100.
76. Sadeh M, Braham J, Modan M. Effects of anticholinergic drugs on memory in Parkinson's disease. Arch Neurol 1982; 39: 666-7.
77. Scott R, Gregory R, Hines N, Carroll C, Hyman N, Papanasstasiou V, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. Brain 1998; 121: 659-75.
78. Shatz MW. WAIS practice effects in clinical neuropsychology. J Clin Neuropsychol 1981; 3: 171-9.
79. Soukup VM, Ingram F, Schiess MC, Bonnen JG, Nauta HJ, et al. Cognitive sequelae of unilateral posteroventral pallidotomy [see comments]. Arch Neurol 1997; 54: 947-50. Comment in: Arch Neurol 1997; 55: 881-3.
80. Soukup VM, Ingram F, Schiess MC, Bonnen JG, Nauta HJ, et al. Cognitive sequelae of unilateral posteroventral pallidotomy [see comments]. Arch Neurol 1997; 54: 947-50. Comment in: Arch Neurol 1997; 55: 881-3.
81. Starr PA, Vitek JL, Bakay RA. Ablative surgery and deep brain stimulation for Parkinson's disease. [Review]. Neurosurgery 1998; 43: 989-1013.
82. Taylor A, Saint-Cyr JA, Lang AE. Dementia prevalence in Parkinson's disease [letter]. Lancet 1985; 1: 1037.
83. Taylor A, Saint-Cyr JA, Lang AE. Parkinson's disease: cognitive changes in relation to treatment response. Brain 1987; 110: 35-51.
84. Trepanier LL, Saint-Cyr JA, Lozano AM, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 1998; 51: 207-15.
85. Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997; 49: 1072-7.
86. Yokoyama T, Imamura Y, Sugiyama K, Nishizawa S, Yokota N, Ohta S, et al. Prefrontal dysfunction following unilateral posteroventral pallidotomy in Parkinson's disease. J Neurosurg 1999; 90: 1005-10.
87. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic indications. Neurology 1985; 35: 522-6.